Clinical Trial Update: A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas [Phase 2]

View source ↗

Summary

This Phase II randomized trial compares EPOCH II alone to EPOCH II with immunotherapy in Hodgkin lymphoma and Non-Hodgkin lymphoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hodgkin's Disease, Non Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED